BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 208 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $439 | +47.8% | 62,144 | +48.2% | 0.00% | 0.0% |
| Q2 2023 | $297 | -7.5% | 41,931 | +9.2% | 0.00% | 0.0% |
| Q1 2023 | $321 | +174.4% | 38,404 | +279.4% | 0.00% | – |
| Q4 2022 | $117 | -99.9% | 10,121 | +14.5% | 0.00% | – |
| Q3 2022 | $111,000 | +18.1% | 8,837 | 0.0% | 0.00% | – |
| Q2 2022 | $94,000 | -38.6% | 8,837 | 0.0% | 0.00% | – |
| Q1 2022 | $153,000 | +10.1% | 8,837 | -11.9% | 0.00% | – |
| Q4 2021 | $139,000 | -4.1% | 10,030 | 0.0% | 0.00% | – |
| Q3 2021 | $145,000 | -8.2% | 10,030 | 0.0% | 0.00% | – |
| Q2 2021 | $158,000 | +24.4% | 10,030 | -20.1% | 0.00% | – |
| Q1 2021 | $127,000 | +89.6% | 12,552 | +38.4% | 0.00% | – |
| Q4 2020 | $67,000 | +116.1% | 9,067 | 0.0% | 0.00% | – |
| Q3 2020 | $31,000 | -27.9% | 9,067 | 0.0% | 0.00% | – |
| Q2 2020 | $43,000 | +207.1% | 9,067 | +28.1% | 0.00% | – |
| Q1 2020 | $14,000 | -41.7% | 7,076 | 0.0% | 0.00% | – |
| Q4 2019 | $24,000 | -52.0% | 7,076 | -46.9% | 0.00% | – |
| Q2 2019 | $50,000 | -53.7% | 13,336 | 0.0% | 0.00% | – |
| Q1 2019 | $108,000 | +89.5% | 13,336 | +82.7% | 0.00% | – |
| Q4 2018 | $57,000 | +1.8% | 7,300 | 0.0% | 0.00% | – |
| Q3 2018 | $56,000 | +33.3% | 7,300 | 0.0% | 0.00% | – |
| Q2 2018 | $42,000 | +20.0% | 7,300 | 0.0% | 0.00% | – |
| Q1 2018 | $35,000 | -2.8% | 7,300 | 0.0% | 0.00% | – |
| Q4 2017 | $36,000 | -5.3% | 7,300 | 0.0% | 0.00% | – |
| Q3 2017 | $38,000 | -5.0% | 7,300 | 0.0% | 0.00% | – |
| Q2 2017 | $40,000 | -34.4% | 7,300 | 0.0% | 0.00% | – |
| Q1 2017 | $61,000 | +32.6% | 7,300 | 0.0% | 0.00% | – |
| Q4 2016 | $46,000 | -28.1% | 7,300 | -50.0% | 0.00% | – |
| Q3 2016 | $64,000 | +204.8% | 14,600 | +100.0% | 0.00% | – |
| Q2 2016 | $21,000 | 0.0% | 7,300 | 0.0% | 0.00% | – |
| Q1 2016 | $21,000 | -72.0% | 7,300 | 0.0% | 0.00% | – |
| Q4 2015 | $75,000 | -9.6% | 7,300 | 0.0% | 0.00% | – |
| Q3 2015 | $83,000 | -23.9% | 7,300 | 0.0% | 0.00% | – |
| Q2 2015 | $109,000 | +65.2% | 7,300 | 0.0% | 0.00% | – |
| Q1 2015 | $66,000 | -25.8% | 7,300 | 0.0% | 0.00% | – |
| Q4 2014 | $89,000 | +23.6% | 7,300 | 0.0% | 0.00% | – |
| Q3 2014 | $72,000 | – | 7,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |